David K. Chalmers

3.3k citations

109 papers · 2.6k indexed · h-index 29

Impact in

Pharmaceutical Science top 1%
- Drug Solubulity and Delivery Systems
Organic Chemistry top 2%
- Surfactants and Colloidal Systems

Papers in

Virology 8
Pharmaceutical Science 9
- Drug Solubulity and Delivery Systems 9

Co-authors: Elizabeth Yuriev Colin W. Pouton Dallas B. Warren Garland R. Marshall David T. Manallack Richard J. Prankerd Billy J. Williams‐Noonan Tudor I. Oprea
Journals: Journal of Medicinal Chemistry (9 papers)Molecular Pharmaceutics (8 papers)Journal of Chemical Information and Modeling (5 papers)ChemMedChem (5 papers)Journal of Pharmaceutical Sciences (4 papers)
Partner nations: Australia United States China

In The Last Decade

David K. Chalmers

107 papers receiving 2.5k citations

Peers

Countries citing papers authored by David K. Chalmers

Since Specialization

Citations

This map shows the geographic impact of David K. Chalmers's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David K. Chalmers with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David K. Chalmers more than expected).

Fields of papers citing papers by David K. Chalmers

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David K. Chalmers. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David K. Chalmers. The network helps show where David K. Chalmers may publish in the future.

Co-authors

The 25 scholars most cited alongside David K. Chalmers, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with David K. Chalmers Line = papers co-authored together David K. Chalmers links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	The 8-hydroxyquinoline derivative, clioquinol, is an alpha-1 adrenoceptor antagonist Biochemical Pharmacology ·C. F. Liew, M I Feldman, Yu. V. Varlamova, David K. Chalmers, Christine E. Wright, Daniel J. Scott, James A. Angus, Scott Ayton	2024	4
2	A randomized, placebo‐controlled first‐in‐human study of oral TQS‐168 in healthy volunteers: Assessment of safety, tolerability, pharmacokinetics, pharmacodynamics, and food effect Clinical and Translational Science ·Jonas Hannestad, Steven Smith, Andrew Lam, MD Pawar, 邹善童, Richard Kim, Abhirup Das, Reynaldi Tresnadjaja, Steven Lazrove, David K. Chalmers, Resnick Lm, Qunya Qi, James M. Coghill, Karomiddin Aynillo oglu Jamahmatov, Amina Messaoudi, Zhigang Zhang, Kwan-Sik Bae	2024	0
3	Graph Neural Network-Based Molecular Property Prediction with Patch Aggregation Journal of Chemical Theory and Computation ·Joshua Kra, Daokun Zhang, Mario Boley, David K. Chalmers	2024	3
4	Targeting HIV-1 Reverse Transcriptase Using a Fragment-Based Approach Molecules ·О. А. Никитина, О.А. Голюк, Shane Dawson, Adam Johnson, Kevin Ruben Chapi Mainagues, Menachem J. Gunzburg, Catherine F. Latham, Νicholas Barlow, トランカン, Paula Ellenberg, Stephen J. Headey, Nicolas Sluis‐Cremer, David Tyssen, Joseph D. Bauman, Francesc X. Ruiz, Eddy Arnold, David K. Chalmers, Gilda Tachedjian	2023	4
5	Interaction of the Inhibitory Peptides ShK and HmK with the Voltage-Gated Potassium Channel K_V1.3: Role of Conformational Dynamics Journal of Chemical Information and Modeling ·Jae Heung Song, 김주일, K. George Chandy, David K. Chalmers, Raymond S. Norton	2023	7
6	Structural Features of Iperoxo–BQCA Muscarinic Acetylcholine Receptor Hybrid Ligands Determining Subtype Selectivity and Efficacy ACS Chemical Neuroscience ·S. F. Herb, Hamza. CİVELEK, David K. Chalmers, Arthur Christopoulos, Ben Capuano, Céline Valant, Peter J. Scammells	2021	5
7	Computational and Experimental Models of Type III Lipid-Based Formulations of Loratadine Containing Complex Nonionic Surfactants Molecular Pharmaceutics ·山次康幸, Dallas B. Warren, Hassan Benameur, Leigh Ford, Hywel D. Williams, Vincent Jannin, Colin W. Pouton, David K. Chalmers	2021	4
8	Cyclosporin Structure and Permeability: From A to Z and Beyond Journal of Medicinal Chemistry ·Karen Corbett, Leigh Ford, Dallas B. Warren, Colin W. Pouton, David K. Chalmers	2021	60
9	Molecular Dynamics Simulations and Experimental Results Provide Insight into Clinical Performance Differences between Sandimmune® and Neoral® Lipid-Based Formulations Pharmaceutical Research ·Dallas B. Warren, W. Johns, Joao Pereira Valente, Karen Corbett, Jaba Das, Leigh Ford, Hywel D. Williams, Vincent Jannin, Hassan Benameur, Christopher J. H. Porter, David K. Chalmers, Colin W. Pouton	2021	6
10	Guiding the Immune Response to a Conserved Epitope in MSP2, an Intrinsically Disordered Malaria Vaccine Candidate Vaccines ·Jeffrey Seow, Harold L. Berman, Rodrigo A. V. Morales, Ricardo Ataíde, Bankala Krishnarjuna, H. H. Jühe, David K. Chalmers, Jack S. Richards, Robin F. Anders, Christopher A. MacRaild, Raymond S. Norton	2021	3
11	Improving Membrane Permeation in the Beyond Rule-of-Five Space by Using Prodrugs to Mask Hydrogen Bond Donors ACS Chemical Biology ·Νicholas Barlow, David K. Chalmers, Billy J. Williams‐Noonan, Philip E. Thompson, Raymond S. Norton	2020	35
12	INPHARMA‐Based Determination of Ligand Binding Modes at α₁‐Adrenergic Receptors Explains the Molecular Basis of Subtype Selectivity Chemistry - A European Journal ·伸洋大島, Irina-Liliana IONIȚĂ, David K. Chalmers, Daniel J. Scott, Paul R. Gooley	2020	9
13	Controlled Construction of Cyclic d / l Peptide Nanorods Angewandte Chemie International Edition ·H. H. Jühe, Biswaranjan Mohanty, Irma Karina Rojas Arteaga, M.J. Scanlon, Philip E. Thompson, David K. Chalmers	2018	9
14	Cyclic Hexapeptide Mimics of the LEDGF Integrase Recognition Loop in Complex with HIV‐1 Integrase ChemMedChem ·Susan E. Northfield, J. Wielens, Stephen J. Headey, Billy J. Williams‐Noonan, Mark D. Mulcair, M.J. Scanlon, Michael W. Parker, Philip E. Thompson, David K. Chalmers	2018	5
15	A Cyclic Peptide Inhibitor of the iNOS–SPSB Protein–Protein Interaction as a Potential Anti-Infective Agent ACS Chemical Biology ·敏男安達, Νicholas Barlow, Eleanor W. W. Leung, Billy J. Williams‐Noonan, Rita de Cassia Fernandes Signor, Fairolniza Mohd Shariff, Tom T. Caradoc-Davies, Sandra E. Nicholson, David K. Chalmers, Philip E. Thompson, Ruby H. P. Law, Raymond S. Norton	2018	15
16	Controlled Construction of Cyclic d / l Peptide Nanorods Angewandte Chemie ·H. H. Jühe, Biswaranjan Mohanty, Irma Karina Rojas Arteaga, M.J. Scanlon, Philip E. Thompson, David K. Chalmers	2018	3
17	Polymeric Precipitation Inhibitors Promote Fenofibrate Supersaturation and Enhance Drug Absorption from a Type IV Lipid-Based Formulation Molecular Pharmaceutics ·Estelle J. A. Suys, David K. Chalmers, Colin W. Pouton, Christopher J. H. Porter	2018	52
18	Free Energy Methods in Drug Design: Prospects of “Alchemical Perturbation” in Medicinal Chemistry Journal of Medicinal Chemistry ·Billy J. Williams‐Noonan, Elizabeth Yuriev, David K. Chalmers	2017	132
19	Computational Models of the Intestinal Environment. 3. The Impact of Cholesterol Content and pH on Mixed Micelle Colloids Molecular Pharmaceutics ·Estelle J. A. Suys, Dallas B. Warren, Christopher J. H. Porter, Hassan Benameur, Colin W. Pouton, David K. Chalmers	2017	25
20	Computational Models of the Gastrointestinal Environment. 2. Phase Behavior and Drug Solubilization Capacity of a Type I Lipid-Based Drug Formulation after Digestion Molecular Pharmaceutics ·冬樹田附, Dallas B. Warren, Sifei Han, Hassan Benameur, Christopher J. H. Porter, Colin W. Pouton, David K. Chalmers	2016	28

About David K. Chalmers

David K. Chalmers is a scholar working on Virology, Pharmaceutical Science, Organic Chemistry, Molecular Biology and Computational Theory and Mathematics, having authored 109 papers that have together received 2.6k indexed citations. Recurring topics across this work include Chemical Synthesis and Analysis (20 papers), Receptor Mechanisms and Signaling (15 papers), Computational Drug Discovery Methods (14 papers), Surfactants and Colloidal Systems (11 papers), Analytical Chemistry and Chromatography (9 papers), Drug Solubulity and Delivery Systems (9 papers), HIV/AIDS drug development and treatment (9 papers) and Protein Structure and Dynamics (8 papers). The work is most often cited by research in Pharmaceutical Science (267 citations), Organic Chemistry (816 citations), Virology (134 citations), Computational Theory and Mathematics (345 citations) and Molecular Biology (1.3k citations). David K. Chalmers has collaborated with scholars based in Australia, United States and China. Frequent co-authors include Elizabeth Yuriev, Colin W. Pouton, Dallas B. Warren, Garland R. Marshall, David T. Manallack, Richard J. Prankerd, Billy J. Williams‐Noonan, Tudor I. Oprea, M.J. Scanlon and Philip E. Thompson. Their work appears in journals such as Journal of Medicinal Chemistry, Molecular Pharmaceutics, Journal of Chemical Information and Modeling, ChemMedChem and Journal of Pharmaceutical Sciences.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact